Company Profile (AI Text) Name: PhorMed Canonical URL: https://wefunder.com/phormed Updated at: 2026-06-06T05:02:11Z Tagline: Join Us in the Fight to Cure Cancer! Pre-Public Limited Time Offer *10% Bonus Discount* Key claims: - Total raised on Wefunder: 204025 | citation: https://wefunder.com/phormed#claim-total-raised - Total investors: 228 | citation: https://wefunder.com/phormed#claim-total-investors Verified facts: - Total raised on Wefunder: 204025 | observed_at: 2026-06-06T05:02:11Z | expires_at: 2026-06-07T05:02:11Z - Total investors: 228 | observed_at: 2026-06-06T05:02:11Z | expires_at: 2026-06-07T05:02:11Z Computed metrics: - total_amount_raised: 204025 - total_investors: 228 - team_size: 10 - featured_investor_count: 2 - faq_count: 5 - recent_post_count: 0 Quick facts: - In a clinical study, we helped 83% of patients beat cancer | citation: https://wefunder.com/phormed#claim-fact-1 - Our drug repairs damaged cells and kills cancer | citation: https://wefunder.com/phormed#claim-fact-2 - On a mission to bring new hope and a brighter future to patients battling life-threatening diseases | citation: https://wefunder.com/phormed#claim-fact-3 - $3.5 million raised from >4,100 investors: Crowdfunding and Angel investors | citation: https://wefunder.com/phormed#claim-fact-4 - Undervalued position, potential to buy low/sell high. PhorMed = $53M; Similar Companies = $290M-1.2B | citation: https://wefunder.com/phormed#claim-fact-5 - FDA allowing “FAST-TRACKING” clinical studies = huge time & cost savings | citation: https://wefunder.com/phormed#claim-fact-6 - Our team has 533 peer-reviewed publications | citation: https://wefunder.com/phormed#claim-fact-7 - Company is ready to start three phase 2 studies | citation: https://wefunder.com/phormed#claim-fact-8 FAQ: - Q: With the Common Stock will we receive annually dividends? A: Adan, thanks for your question. This offering does not include dividends.. - Q: Hi Ben , I have already invested in your company through start engine. 2years back. At that time also your valuation was the same as of today. Why?? Why are you raising funds at same valuation? It is nothing but dilution of shares through unfair practices. Are you people at al... A: Arghya, apologies for the delayed response. Since your purchase the stock prices remain the same so no losses to your investment. The company is hitting milestones and stock price increases happen shortly after. Stand-by for those announcements. - Q: Mr Ben any courage to give any answer??? A: Arghya, please see my response above. - Q: How many shares will my $250 investment secure? A: Larry, thank you for your question. Currently, we are running an early bird special, discounting the share price by 10% from $1.00 to $0.90. A $250 investment will get you 277 shares. - Q: When is this funding round closing? A: Douglas, thank you for your question. We expect to close this round in mid-April 2025.